| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/000992289403300707 © 1994 SAGE Publications Neurodevelopment in Pediatric HIV InfectionThe Use of CAT/CLAMSDepartment of Pediatrics University of Maryland School of Medicine Baltimore, Maryland
Department of Pediatrics University of Maryland School of Medicine Baltimore, Maryland
Department of Pediatrics University of Maryland School of Medicine Baltimore, Maryland
Department of Pediatrics University of Maryland School of Medicine Baltimore, Maryland
Department of Pediatrics University of Maryland School of Medicine Baltimore, Maryland Pediatric neuro-AIDS may be the first clinical manifestation of HIV infection in children born to HIV infected mothers. As part of the neurodevelopmental examination of children, the Clinical Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (CAT/CLAMS) was investigated as a tool for pediatricians to use to monitor the development of children at risk for HIV infection. The CAT/CLAMS was found to detect neurodevelopmental differences between HIV-infected and uninfected children at 12 and 18 months of age. Good correlations were found between the CAT/CLAMS and concurrently administered Bayley Scales of Infant Development. These findings suggest that the CAT/CLAMS should be considered as a part of the neurodevelopmental examination of children at risk for pediatric neuro-AIDS.
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||

